Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Aug 1;66(3):298-301.
doi: 10.1016/j.biopsych.2009.02.018. Epub 2009 Apr 9.

Rapid and Sustained Antidepressant Response With Sleep Deprivation and Chronotherapy in Bipolar Disorder

Affiliations
Randomized Controlled Trial

Rapid and Sustained Antidepressant Response With Sleep Deprivation and Chronotherapy in Bipolar Disorder

Joseph C Wu et al. Biol Psychiatry. .

Abstract

Background: The development of a rapid-acting and sustainable treatment for bipolar disorder (BPD) depression has been a goal for decades. The most widely documented rapid-onset antidepressant therapy is sleep deprivation (SD), which acts within 24-48 hours in 40%-60% of depressed patients. Conventional antidepressants usually require 2-8 weeks to meet response criteria. The delay, which may prolong suffering and increase suicidal risk, underlines the urgency of alternative treatment strategies. This study evaluates the combined efficacy of three established circadian-related treatments (SD, bright light [BL]), sleep phase advance [SPA]) as adjunctive treatment to lithium and antidepressants.

Methods: Forty-nine BPD patients were randomly assigned to a chronotherapeutic augmentation (CAT; SD+ BL+ SPA) or to a medication-only (MED) group. Clinical outcome was assessed using the Hamilton Rating Scale for Depression.

Results: Significant decreases in depression in the CAT versus MED patients were seen within 48 hours of SD and were sustained over a 7-week period.

Conclusions: This is the first study to demonstrate the benefit of adding three noninvasive circadian-related interventions to SD in medicated patients to accelerate and sustain antidepressant responses and provides a strategy for the safe, fast-acting, and sustainable treatment of BPD.

Similar articles

See all similar articles

Cited by 63 articles

See all "Cited by" articles

Publication types

Substances

Feedback